Develops and tests generic tadalafil products. Sells orthopedic wedge seat cushions. Now — the numbers.
This is an established company with proven profits.
The gap is $133.52. In times of high interest rates, a gap like that can squeeze a company.
The market pays 3,362.4× for every dollar this company earns in a year — a price that already assumes things go well.
No analyst target is on record for this company.
An investor who bought at the very peak is down 80% today. The business is the same; what changed most is the price — and the expectations — the market pins on it.
The net profit margin is 65% — still a thick cushion, though costs have been eating into it lately.
Over the last 1 years, sales grew about 20% a year on average.
The stock sits at $0.0001. Under exchange rules, stocks that stay below $1 for too long risk being removed from the market.
This stock swings about 9.5 times as much as the market average. Big rallies — and big drops — can both happen fast.
The company’s market value is 3362 times its annual profit. Even a small disappointment could hit the price hard.
No score published: we hold no usable price for this ticker, and a grade beside a missing price says nothing.
One-line summary: few numbers, an untested story. Keep watching.
Not covered, because the filings we hold do not carry it: the growth trend, earnings execution, the revenue breakdown.